General Motors posted strong financial results for its first quarter Tuesday, but says it will reassess its expectations for 2025 due to auto tariffs. The automaker is pushing back its conference call to discuss its guidance and quarterly results until Thursday, so that it can assess potential tariff changes.

General Motors on Tuesday reported better first-quarter results than analysts had expected, but postponed earnings call by two days amid uncertainty about auto tariffs.

The automaker is pushing back its conference call to discuss its guidance and quarterly results until Thursday, so that it can assess potential tariff changes.

The company disclosed revenue of $13.7 billion and adjusted earnings of $0.92 per share, compared to consensus estimates of $14.1 billion and $0.68, respectively.

Pfizer reported weaker first-quarter results on Tuesday, with revenue falling short of Wall Street estimates, but earnings beating expectations. The US drugmaker reaffirmed its full-year 2025 guidance,

Global pharmaceutical company Pfizer (NYSE:PFE) in Q1 CY2025, with sales falling 7.8% year on year to $13.72 billion. The company’s full-year revenue guidance of $62.5 billion at the midpoint came in 0.